Michelle Busch
University of Rostock(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research, Nanoparticle-Based Drug Delivery, Protein purification and stability
Most-Cited Works
- → Site-Specific Antibody–Drug Conjugation through Glycoengineering(2014)215 cited
- → New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study(2021)41 cited
- → Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates(2012)33 cited
- → Identification and quantitation of vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell cultures(2012)30 cited
- → Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody–drug conjugation(2019)16 cited
- → Design, Synthesis, and in vitro Evaluation of Multivalent Drug Linkers for High‐Drug‐Load Antibody–Drug Conjugates(2018)16 cited
- → Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study(2022)15 cited
- → Well-Defined Aminooxy Terminated N-(2-Hydroxypropyl) Methacrylamide Macromers for Site Specific Bioconjugation of Glycoproteins(2013)14 cited
- → Micro- and Mid-Scale Maleimide-Based Conjugation of Cytotoxic Drugs to Antibody Hinge Region Thiols for Tumor Targeting(2013)14 cited
- → Correction to Well-Defined Aminooxy Terminated N-(2-Hydroxypropyl) Methacrylamide Macromers for Site Specific Bioconjugation of Glycoproteins(2013)3 cited